Biochemical, Structural Analysis, and Docking Studies of Spiropyrazoline Derivatives

Area of Science:

• Medicinal Chemistry
• Molecular Biology
• Computational Chemistry

Background:

• Spiropyrazoline derivatives are explored for their diverse biological activities.
• Targeting cancer cell proliferation and DNA integrity is crucial for effective cancer therapy.

Purpose of the Study:

• To synthesize and evaluate two new spiropyrazoline derivatives for antiproliferative potential.
• To investigate their mechanisms of action, including DNA damage, apoptosis induction, and interaction with PARP1.

Main Methods:

• Antiproliferative assays against eight cancer cell lines.
• Comet assay for DNA damage assessment.
• Fluorescence microscopy for apoptosis and necrosis determination.
• Mitochondrial membrane potential analysis.
• Molecular docking studies and in vitro PARP1 enzyme degradation assays.

Main Results:

• Compound I exhibited potent antiproliferative activity (IC50 = 9.4 µM/L against HL60).
• Compound II induced greater DNA damage in HEC-1-A cells (23%).
• Both compounds induced apoptosis, depolarized mitochondrial membranes, and showed theoretical binding to the PARP1 active site.
• In vitro studies confirmed PARP1 enzyme degradation, with Compound I being more effective.

Conclusions:

• The synthesized spiropyrazoline derivatives possess significant antiproliferative and DNA-damaging properties.
• These compounds induce apoptosis and affect mitochondrial function in cancer cells.
• The compounds demonstrate potential as PARP1 inhibitors, warranting further investigation for cancer treatment.